Home › Meningioma › Indiana › Indianapolis
Meningioma clinical trials in Indianapolis, IN
3 studies for Meningioma are looking for participants at sites in and around Indianapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
RecruitingPhase 2
- Indiana University, Indianapolis
A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
RecruitingPhase 2
- Indiana University Health Neurosurgery Clinic, Indianapolis
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
RecruitingObservational study
- Indiana University, IU Health Methodist Hospital, Indianapolis
Meningioma trials in other cities
- New York City, NY8 studies
- San Francisco, CA7 studies
- Miami, FL7 studies
- Columbus, OH6 studies
- Boston, MA6 studies
- Atlanta, GA5 studies
- San Diego, CA5 studies
- Jacksonville, FL5 studies
- Houston, TX4 studies
- Detroit, MI4 studies
- Durham, NC4 studies
- Arlington, VA4 studies
Other studies in Indianapolis
- Non-Small Cell Lung Cancer32 studies
- Cancer (all types)24 studies
- Heart Failure24 studies
- Obesity22 studies
- Breast Cancer19 studies
- Ovarian Cancer18 studies
- Metastatic Cancer17 studies
- Colorectal Cancer17 studies
- Cardiovascular Disease16 studies
- Lung Cancer16 studies
- Type 1 Diabetes14 studies
- Overweight14 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.